🇺🇸 Ketorolac 15mg in United States

16 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Headache — 3 reports (18.75%)
  2. Nausea — 3 reports (18.75%)
  3. Infusion Related Reaction — 2 reports (12.5%)
  4. Vomiting — 2 reports (12.5%)
  5. Abdominal Discomfort — 1 report (6.25%)
  6. Abdominal Pain — 1 report (6.25%)
  7. Acute Kidney Injury — 1 report (6.25%)
  8. Anaemia — 1 report (6.25%)
  9. Ascites — 1 report (6.25%)
  10. Bladder Dilatation — 1 report (6.25%)

Source database →

Ketorolac 15mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Ketorolac 15mg approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Ketorolac 15mg in United States?

Cairo University is the originator. The local marketing authorisation holder may differ — check the official source linked above.